To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MRPS11TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
348 supporting clones for gene MRPS11 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DW448987 Liver .a 1 to 186 18 to 203   tiling clone,   186/205
(90 %)
3 diff
(98.6 %id)
AB049944   .a 53 to 1187 1 to 1135 exact tiling clone,   1135/1136
(99 %)
1 diff
(100.0 %id)
BE407132 choriocarcinoma, placenta .a 53 to 897 1 to 839       839/943
(88 %)
13 diff
(98.7 %id)
NM_022839.2   .a 53 to 1188 1 to 1136 exact RefSeq,   1136/1136
(100 %)
1 diff
(100.0 %id)
BU601457 mixed (pool of 40 RNAs) .a 264 to 1015 1 to 759 exact     759/760
(99 %)
10 diff
(98.7 %id)
CN299729 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 283 to 979 1 to 697 exact     697/697
(100 %)
3 diff
(99.6 %id)
BG169415 hypernephroma, cell line, Kidney .a 286 to 1051 1 to 758 L170W E171K V172*     758/942
(80 %)
17 diff
(98.2 %id)
BG469026 adenocarcinoma cell line, colon .a 289 to 1084 1 to 796 exact     796/796
(100 %)
5 diff
(99.4 %id)
BG432779 Kidney .a 291 to 1006 1 to 716 T32P I33S C34A T35Q G36A ...     716/716
(100 %)
16 diff
(97.8 %id)
AA337856 endometrium .a 294 to 557 1 to 264       264/264
(100 %)
1 diff
(99.7 %id)
CV570981 cornea, eye .a 294 to 435 1 to 142       142/142
(100 %)
0 diff
(100 %id)
BC032378 Cervix, carcinoma .a 295 to 1186 12 to 903 exact available from MGC, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 892/892
(100 %)
0 diff
(100 %id)
BX281780 cervical carcinoma cell line, cervix .a 295 to 778 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BI258226 cervical carcinoma cell line, cervix .a 295 to 1187 1 to 892 exact     892/902
(98 %)
9 diff
(99.1 %id)
BM693824 eye, lens .a 296 to 759 1 to 464   fully sequenced, Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 464/464
(100 %)
0 diff
(100 %id)
BI602446 brain, hypothalamus .a 300 to 1083 1 to 788 P55T P84L C186L R187P     788/788
(100 %)
15 diff
(98.1 %id)
DB486995 hypothalamus .a 301 to 747 1 to 447       447/447
(100 %)
3 diff
(99.4 %id)
DB495087 hypothalamus .a 301 to 794 1 to 494       494/494
(100 %)
0 diff
(100 %id)
CT002516 T-Lymphocytes .a 301 to 1056 1 to 758 exact     758/758
(100 %)
4 diff
(99.5 %id)
CN299730 embryonic stem cells, DMSO-treated H9 cellline .a 303 to 1038 1 to 736 exact     736/736
(100 %)
4 diff
(99.5 %id)
TI_45216608   .a 303 to 1083 88 to 872 P55T P84L C186L R187P     785/872
(90 %)
18 diff
(98.0 %id)
CR992855 T-Lymphocytes .a 305 to 1165 1 to 862 exact     862/862
(100 %)
2 diff
(99.8 %id)
BF965142 muscle (skeletal) .a 307 to 796 1 to 494       494/928
(53 %)
10 diff
(99.0 %id)
BM822392 stomach .a 307 to 554 1 to 249       249/249
(100 %)
2 diff
(99.2 %id)
AK026165   .a 308 to 1186 1 to 879 N52Y available from FLJ, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 879/879
(100 %)
1 diff
(99.9 %id)
AK222933 Kidney .a 308 to 1186 1 to 879 N52Y AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 879/879
(100 %)
1 diff
(99.9 %id)
AK223152 Human lung .a 308 to 1907 1 to 1600 L40F tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 1600/1600
(100 %)
6 diff
(99.7 %id)
AK315407 colon .a 308 to 902 1 to 595 exact     595/595
(100 %)
0 diff
(100 %id)
CD387798 embryonic trophoblasts, made from WA01 stemcells .a 308 to 1149 26 to 872 H57R     847/885
(95 %)
13 diff
(98.6 %id)
DB491414 hypothalamus .a 308 to 496 1 to 190       190/192
(98 %)
5 diff
(97.4 %id)
BG281892 melanotic melanoma, skin .a 308 to 1040 1 to 731 L170W E171K V172*     731/731
(100 %)
3 diff
(99.6 %id)
BM846313 myeloma .a 308 to 883 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BM846038 myeloma .a 308 to 678 1 to 370       370/370
(100 %)
2 diff
(99.5 %id)
BM822044 stomach .a 308 to 697 1 to 390       390/390
(100 %)
1 diff
(99.8 %id)
DA431593 colon .a 309 to 823 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
BQ050879 leiomyosarcoma, uterus .a 309 to 1146 12 to 863 exact     852/1031
(82 %)
47 diff
(95.5 %id)
DA714206   .a 309 to 861 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
DB248975 uterus .a 309 to 866 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA897522 skeletal muscle .a 310 to 852 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BF700663 brain, primitive neuroectoderm .a 312 to 1029 1 to 719 V24S V25W A26P R27E T28R ...     717/923
(77 %)
51 diff
(94.5 %id)
AA355412   .a 315 to 573 1 to 259       259/259
(100 %)
0 diff
(100 %id)
AA227605 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 315 to 719 1 to 398   fully sequenced,   398/398
(100 %)
11 diff
(97.3 %id)
BI224114 cervical carcinoma cell line, cervix .a 315 to 1023 23 to 741 V25C A26G R27Q T28N P29A ...     719/744
(96 %)
29 diff
(96.2 %id)
CB109165 Liver .a 315 to 821 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BM846571 myeloma .a 317 to 907 1 to 591 G155W     591/591
(100 %)
1 diff
(99.9 %id)
TI_1948239536   .a 317 to 843 125 to 651       527/553
(95 %)
6 diff
(99.0 %id)
TI_1948239537   .a 317 to 674 133 to 490       358/385
(92 %)
6 diff
(98.5 %id)
EL733687 mixed .a 318 to 901 1 to 584       584/657
(88 %)
1 diff
(99.9 %id)
BG684233 B-cells, primary B-cells from tonsils (cell line) .a 318 to 1057 1 to 738 V149X P180Q I181S P182H H183T ...     738/738
(100 %)
5 diff
(99.4 %id)
BG685244 B-cells, primary B-cells from tonsils (cell line) .a 318 to 1176 1 to 873 P180Q I181S P182H H183T N184T ...     873/908
(96 %)
15 diff
(98.4 %id)
BG768285 melanotic melanoma, high MDR (cell line), skin .a 319 to 1036 1 to 718       718/719
(99 %)
2 diff
(99.8 %id)
TI_149308607   .a 319 to 1188 952 to 88   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 865/983
(87 %)
15 diff
(98.5 %id)
CN299727 embryonic stem cells, DMSO-treated H9 cellline .a 320 to 732 1 to 413       413/413
(100 %)
2 diff
(99.6 %id)
BG490325 large cell carcinoma, lung .a 320 to 1047 1 to 727       727/730
(99 %)
2 diff
(99.8 %id)
BI259243 cervical carcinoma cell line, cervix .a 320 to 1023 1 to 705       705/707
(99 %)
2 diff
(99.8 %id)
R17503 whole brain .a 321 to 598 1 to 276       276/452
(61 %)
6 diff
(98.7 %id)
BI918740 brain .a 321 to 1147 33 to 860       828/860
(96 %)
8 diff
(99.1 %id)
TI_57241115   .a 321 to 1147 33 to 860       828/860
(96 %)
8 diff
(99.1 %id)
AW816694 stomach .a 323 to 577 264 to 12       253/264
(95 %)
0 diff
(100 %id)
BF906638 stomach .a 323 to 577 258 to 5     Submitted on the opposite strand 254/258
(98 %)
0 diff
(100 %id)
BI047867 stomach .a 323 to 449 206 to 80       127/206
(61 %)
0 diff
(100 %id)
CR602512 Neuroblastoma Cot 50-normalized .a 323 to 1190 1 to 868       868/868
(100 %)
0 diff
(100 %id)
BX403163 Neuroblastoma Cot 50-normalized .a 323 to 1190 1 to 868   fully sequenced,   868/868
(100 %)
5 diff
(99.5 %id)
BG178675 adenocarcinoma, cell line, Prostate .a 323 to 1047 13 to 724       712/943
(75 %)
20 diff
(97.9 %id)
BG286296 bladder, transitional cell papilloma, cell line .a 323 to 1190 1 to 865       865/882
(98 %)
38 diff
(95.7 %id)
BM046180 carcinoma, cell line, Prostate .a 323 to 1179 1 to 859       859/860
(99 %)
18 diff
(98.0 %id)
AA035005 uterus .a 324 to 833 1 to 517   fully sequenced,   514/514
(100 %)
19 diff
(96.4 %id)
AA035106 uterus .a 324 to 691 1 to 371       371/371
(100 %)
9 diff
(97.6 %id)
CT003413 T-Lymphocytes .a 324 to 994 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
CN299728 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 325 to 1085 1 to 764       764/764
(100 %)
3 diff
(99.7 %id)
BG291250 bladder, transitional cell papilloma, cell line .a 325 to 1127 1 to 794       794/912
(87 %)
21 diff
(97.7 %id)
CA389674 eye, RPE/choroid .a 327 to 810 1 to 484       484/484
(100 %)
3 diff
(99.4 %id)
BI256407 cervical carcinoma cell line, cervix .a 327 to 1190 1 to 865       865/875
(98 %)
10 diff
(98.9 %id)
BI047539 stomach .a 328 to 571 1 to 240       240/240
(100 %)
11 diff
(95.5 %id)
CN299731 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 328 to 723 1 to 396       396/396
(100 %)
7 diff
(98.3 %id)
W87516 liver and spleen .a 328 to 704 1 to 387       387/439
(88 %)
18 diff
(95.9 %id)
AA112021 muscle, skeletal muscle .a 328 to 731 1 to 404       404/404
(100 %)
5 diff
(98.8 %id)
TI_57173490   .a 328 to 1180 28 to 877       850/877
(96 %)
21 diff
(97.7 %id)
BM823708 Ascites, stomach .a 328 to 592 1 to 265       265/265
(100 %)
9 diff
(96.7 %id)
AA357479 Prostate .a 329 to 577 1 to 248       248/253
(98 %)
4 diff
(98.5 %id)
BG030305 breast, mammary adenocarcinoma, cell line .a 329 to 1164 1 to 842       842/1069
(78 %)
26 diff
(97.6 %id)
BG577063 breast, mammary adenocarcinoma, cell line .a 329 to 1190 11 to 872       862/875
(98 %)
19 diff
(97.9 %id)
BI826447 brain, medulla .a 329 to 1180 1 to 849       849/849
(100 %)
16 diff
(98.2 %id)
BQ951174 large cell carcinoma, lung .a 329 to 1188 20 to 882       863/936
(92 %)
16 diff
(98.3 %id)
TI_154194304   .a 329 to 1184 48 to 900   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 853/853
(100 %)
18 diff
(97.9 %id)
BE047800 brain, tumor, 5 pooled (see description) .a 330 to 886 1 to 557       557/564
(98 %)
5 diff
(99.2 %id)
BG028391 Bone, osteosarcoma, cell line .a 330 to 1011 1 to 689       689/909
(75 %)
15 diff
(98.4 %id)
BG250151 adenocarcinoma, cell line, Liver .a 330 to 1170 1 to 835       835/912
(91 %)
23 diff
(97.5 %id)
BG250651 adenocarcinoma, cell line, Liver .a 330 to 1032 1 to 701       701/996
(70 %)
8 diff
(99.2 %id)
CF128430 Chondrosarcoma Lung Metastasis cell lines, lung .a 330 to 1080 1 to 751       751/751
(100 %)
5 diff
(99.4 %id)
AA332419 Embryo, 8 weeks .a 332 to 605 1 to 274       274/274
(100 %)
0 diff
(100 %id)
BU528066 epidermoid carcinoma, cell line, lung .a 332 to 971 1 to 644       644/846
(76 %)
6 diff
(99.3 %id)
BU855902 ovary, teratocarcinoma, cell line .a 332 to 1190 1 to 862       862/944
(91 %)
14 diff
(98.6 %id)
AW955813   .a 333 to 997 1 to 665       665/669
(99 %)
6 diff
(99.2 %id)
BE313140 brain, neuroblastoma .a 334 to 1047 1 to 710       710/710
(100 %)
4 diff
(99.5 %id)
BM804258 eye, retinoblastoma .a 334 to 1190 1 to 862       862/1072
(80 %)
37 diff
(96.6 %id)
AA188269   .a 335 to 716 1 to 383   fully sequenced, Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 383/383
(100 %)
7 diff
(98.2 %id)
AA100457 colon, tumor .a 336 to 754 1 to 419       419/419
(100 %)
7 diff
(98.4 %id)
AI750579 Bone, Hip .a 336 to 678 17 to 359       343/359
(95 %)
6 diff
(98.4 %id)
BP423600 small intestine .a 338 to 881 1 to 544     Submitted on the opposite strand 544/544
(100 %)
0 diff
(100 %id)
BQ684284 melanotic melanoma, cell line, skin .a 339 to 1182 1 to 846   AAA   846/852
(99 %)
8 diff
(99.1 %id)
BE261031 brain, neuroblastoma .a 348 to 949 1 to 601       601/601
(100 %)
1 diff
(99.9 %id)
BE265622 lung, small cell carcinoma .a 348 to 921 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BE888948 leiomyosarcoma, uterus .a 351 to 1083 1 to 726       726/732
(99 %)
15 diff
(98.0 %id)
BE877128 large cell carcinoma, undifferentiated, lung .a 352 to 1116 1 to 769       769/769
(100 %)
10 diff
(98.7 %id)
W73343 heart .a 354 to 780 1 to 427       427/427
(100 %)
9 diff
(97.9 %id)
BQ014471 Chondrosarcoma, Left Pubic Bone .a 385 to 1186 808 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 790/829
(95 %)
15 diff
(98.2 %id)
TI_1948145274   .a 385 to 901 655 to 138       518/1444
(35 %)
9 diff
(99.4 %id)
TI_1948144829   .a 392 to 901 640 to 128       513/1014
(50 %)
19 diff
(98.2 %id)
BQ084447 stomach .a 408 to 571 1 to 164       164/164
(100 %)
0 diff
(100 %id)
BF978356 melanotic melanoma, high MDR, skin .a 411 to 1163 1 to 744       744/751
(99 %)
31 diff
(95.9 %id)
BU156947 epithelioid carcinoma, Pancreas .a 418 to 1190 1 to 773       773/773
(100 %)
1 diff
(99.9 %id)
BM979790 lung, Primary Lung Epithelial Cells .a 448 to 1188 754 to 17   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 738/738
(100 %)
5 diff
(99.4 %id)
CA306001 Alveolar Macrophage, lung .a 454 to 1185 747 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 729/729
(100 %)
5 diff
(99.4 %id)
CA310139 Alveolar Macrophage, lung .a 464 to 1188 743 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 725/726
(99 %)
0 diff
(100 %id)
BU622364 cell lines, Chondrosarcoma .a 467 to 1186 736 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 718/718
(100 %)
5 diff
(99.4 %id)
BU625880 cell lines, Enchondroma .a 468 to 1188 736 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 718/718
(100 %)
4 diff
(99.5 %id)
BI048211 stomach .a 470 to 569 102 to 3       100/102
(98 %)
1 diff
(99.1 %id)
BU956513 adenocarcinoma, cell line, breast .a 483 to 1186 1 to 704       704/704
(100 %)
1 diff
(99.9 %id)
TI_158431199   .a 501 to 1188 791 to 96   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 696/801
(86 %)
12 diff
(98.6 %id)
CA309499 Alveolar Macrophage, lung .a 512 to 1186 694 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 676/676
(100 %)
1 diff
(99.9 %id)
BM694416 eye, RPE and Choroid .a 519 to 759 1 to 241   fully sequenced, Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 241/241
(100 %)
0 diff
(100 %id)
BU753478 placenta .a 543 to 1188 661 to 16   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
BQ020942 lung, Metastatic Chondrosarcoma .a 548 to 1186 657 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 639/639
(100 %)
0 diff
(100 %id)
BM998471 lung, Metastatic Chondrosarcoma .a 548 to 1186 657 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 639/639
(100 %)
2 diff
(99.7 %id)
BQ013634 placenta .a 564 to 1185 638 to 18   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 621/621
(100 %)
1 diff
(99.9 %id)
BX403162 Neuroblastoma Cot 50-normalized .a 568 to 1161 593 to 1   fully sequenced,   593/593
(100 %)
31 diff
(94.8 %id)
BM754218 Ascites, stomach .a 577 to 710 1 to 134       134/134
(100 %)
2 diff
(98.6 %id)
BG178287 adenocarcinoma, cell line, Prostate .a 591 to 1190 1 to 597       597/605
(98 %)
8 diff
(98.7 %id)
TI_1948239251   .a 596 to 901 904 to 599     Submitted on the opposite strand 306/1292
(23 %)
9 diff
(99.4 %id)
TI_1948239252   .a 596 to 901 919 to 608     Submitted on the opposite strand 312/1192
(26 %)
8 diff
(99.4 %id)
TI_1948240124   .a 596 to 901 908 to 597     Submitted on the opposite strand 312/1415
(22 %)
14 diff
(99.1 %id)
TI_1948240125   .a 596 to 901 906 to 599     Submitted on the opposite strand 308/1159
(26 %)
9 diff
(99.3 %id)
TI_1948239825   .a 599 to 901 907 to 602     Submitted on the opposite strand 306/1162
(26 %)
9 diff
(99.3 %id)
TI_1948239824   .a 607 to 901 903 to 609     Submitted on the opposite strand 295/1385
(21 %)
9 diff
(99.4 %id)
AA235024 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 608 to 724 1 to 117       117/118
(99 %)
14 diff
(88.2 %id)
CB111811 Liver .a 608 to 1186 1 to 579   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
TI_159705981   .a 618 to 1185 600 to 32   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 569/982
(57 %)
1 diff
(99.9 %id)
AI636464 Kidney, renal cell tumor .a 630 to 1190 567 to 6       562/567
(99 %)
17 diff
(97.1 %id)
AI750580 Bone, Hip .a 631 to 1152 526 to 5       522/526
(99 %)
0 diff
(100 %id)
AA585473   .a 632 to 866 1 to 230       230/247
(93 %)
18 diff
(92.8 %id)
BM796783 Ascites, stomach .a 639 to 1153 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BQ010964 placenta .a 642 to 1186 563 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 545/545
(100 %)
2 diff
(99.7 %id)
BQ018299 lung, Metastatic Chondrosarcoma .a 645 to 1188 559 to 17   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 543/543
(100 %)
1 diff
(99.9 %id)
CD742961 Alveolar Macrophage, lung .a 646 to 1186 559 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 541/541
(100 %)
0 diff
(100 %id)
CF528500 placenta .a 647 to 1188 557 to 16   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 542/542
(100 %)
0 diff
(100 %id)
BF111443 pooled .a 648 to 1190 547 to 5       543/547
(99 %)
4 diff
(99.3 %id)
CV356723 kidney_tumor .a 654 to 1154 28 to 538       511/538
(94 %)
41 diff
(92.4 %id)
AI039662   .a 654 to 1190 541 to 6       536/545
(98 %)
4 diff
(99.3 %id)
AI432190 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 657 to 1310 653 to 3       651/653
(99 %)
5 diff
(99.3 %id)
BX380254 Placenta Cot 25-normalized .a 660 to 1256 600 to 1       600/600
(100 %)
20 diff
(96.7 %id)
BX380255 Placenta Cot 25-normalized .a 660 to 1310 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
CV356755 kidney_tumor .a 663 to 1160 521 to 27     Submitted on the opposite strand 495/521
(95 %)
6 diff
(98.9 %id)
AI264676 Kidney .a 667 to 1185 523 to 1       523/523
(100 %)
5 diff
(99.1 %id)
AI571831 anaplastic oligodendroglioma, brain .a 673 to 1186 513 to 1       513/515
(99 %)
15 diff
(97.1 %id)
AA353565   .a 676 to 1030 1 to 356       356/356
(100 %)
2 diff
(99.5 %id)
AI151373 placenta .a 683 to 1190 509 to 5       505/513
(98 %)
7 diff
(98.7 %id)
AA181190   .a 686 to 1186 518 to 20   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 499/499
(100 %)
15 diff
(97.0 %id)
BQ344499 nervous_tumor .a 689 to 1075 385 to 1       385/385
(100 %)
5 diff
(98.8 %id)
CV311592 marrow .a 690 to 1154 464 to 1     Submitted on the opposite strand 464/464
(100 %)
7 diff
(98.5 %id)
DB576901 hypothalamus .a 697 to 1184 1 to 488     Submitted on the opposite strand 488/488
(100 %)
2 diff
(99.6 %id)
BU731060 eye, RPE and Choroid .a 698 to 1188 509 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
BM670886 eye, lens .a 698 to 1185 507 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 489/489
(100 %)
2 diff
(99.6 %id)
AI554856 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 699 to 1187 490 to 2       489/490
(99 %)
0 diff
(100 %id)
AI373711 uterus .a 702 to 1186 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
AA227851 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 708 to 1186 477 to 1   fully sequenced,   477/477
(100 %)
7 diff
(98.6 %id)
AA886963 pooled germ cell tumors .a 712 to 1185 473 to 1       473/477
(99 %)
12 diff
(97.5 %id)
CV319560 nervous_tumor .a 716 to 1054 338 to 1     Submitted on the opposite strand 338/338
(100 %)
9 diff
(97.4 %id)
AA904468 pooled .a 718 to 1190 472 to 1       472/473
(99 %)
8 diff
(98.4 %id)
CX163380 human embryonic stem cells differentiated toan early endodermal cell type .a 726 to 1553 1 to 828       828/828
(100 %)
4 diff
(99.6 %id)
DW412123 Liver .a 728 to 1038 16 to 326       311/326
(95 %)
7 diff
(97.9 %id)
AW057916 fibrotheoma, ovary .a 728 to 1185 461 to 1       461/514
(89 %)
12 diff
(97.7 %id)
F20720 pectoral muscle (after mastectomy) .a 731 to 1059 1 to 329       329/329
(100 %)
0 diff
(100 %id)
AW263443 brain, three pooled meningiomas .a 735 to 1185 453 to 2       452/456
(99 %)
2 diff
(99.6 %id)
AI660883 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 736 to 1190 455 to 2       454/457
(99 %)
1 diff
(99.8 %id)
W95256 heart .a 738 to 1136 1 to 403       403/403
(100 %)
11 diff
(97.3 %id)
AA902875 Kidney .a 741 to 1185 455 to 12   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 444/444
(100 %)
7 diff
(98.5 %id)
AI080510 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 741 to 1186 445 to 1       445/445
(100 %)
9 diff
(98.0 %id)
AI217114   .a 742 to 1185 448 to 5       444/448
(99 %)
0 diff
(100 %id)
DW441972 Liver .a 743 to 963 16 to 236       221/236
(93 %)
6 diff
(97.5 %id)
AA464607 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 743 to 1186 442 to 1       442/448
(98 %)
7 diff
(98.5 %id)
BE932685 head_neck .a 752 to 1185 435 to 2       434/445
(97 %)
5 diff
(98.9 %id)
AA100458 colon, tumor .a 756 to 1173 417 to 1       417/417
(100 %)
6 diff
(98.6 %id)
AI348664 carcinoid, lung .a 756 to 1186 431 to 1       431/431
(100 %)
0 diff
(100 %id)
BE932688 head_neck .a 760 to 1191 444 to 11       434/450
(96 %)
1 diff
(99.8 %id)
AW246715 lung, small cell carcinoma .a 762 to 1185 434 to 11   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
BQ010778 placenta .a 763 to 1185 441 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 423/423
(100 %)
1 diff
(99.8 %id)
AI336179 lung .a 765 to 1185 421 to 1       421/421
(100 %)
0 diff
(100 %id)
BI008287 kidney_tumor .a 772 to 1154 388 to 1       388/388
(100 %)
14 diff
(96.4 %id)
AA774506 heart .a 780 to 1190 411 to 2       410/411
(99 %)
0 diff
(100 %id)
AA765035 germinal center B cell .a 780 to 1190 436 to 30       407/437
(93 %)
0 diff
(100 %id)
AA989396 2 pooled tumors (clear cell type), Kidney .a 780 to 1190 415 to 7       409/417
(98 %)
0 diff
(100 %id)
AL110094   .a 794 to 1309 539 to 24   AAA Submitted on the opposite strand 516/524
(98 %)
0 diff
(100 %id)
AA599048 lung, lung carcinoma .a 794 to 1187 393 to 1       393/395
(99 %)
6 diff
(98.5 %id)
AA749257 germinal center B cell .a 794 to 1190 404 to 6       399/408
(97 %)
0 diff
(100 %id)
AW194208 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 794 to 1188 408 to 14   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 395/436
(90 %)
12 diff
(97.3 %id)
AI400073 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 795 to 1187 392 to 1       392/392
(100 %)
7 diff
(98.3 %id)
CF528797 placenta .a 799 to 1185 404 to 18   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 387/389
(99 %)
2 diff
(99.5 %id)
BF772814 epid_tumor .a 801 to 1159 398 to 40     Submitted on the opposite strand 359/398
(90 %)
0 diff
(100 %id)
AA035504 uterus .a 801 to 1186 392 to 1       392/392
(100 %)
10 diff
(97.5 %id)
AA805569 germinal center B cell .a 801 to 1186 398 to 15   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 384/384
(100 %)
4 diff
(99.0 %id)
AI400059 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 801 to 1185 386 to 1       386/386
(100 %)
1 diff
(99.8 %id)
W73512 heart .a 803 to 1185 384 to 1       384/384
(100 %)
5 diff
(98.7 %id)
BM129094 Islets of Langerhans, Pancreas .a 803 to 1190 1 to 388   fully sequenced,   388/388
(100 %)
2 diff
(99.5 %id)
AA035006 uterus .a 811 to 1186 380 to 1   fully sequenced,   380/380
(100 %)
12 diff
(96.9 %id)
BI009190 kidney_tumor .a 818 to 937 30 to 148       119/148
(80 %)
6 diff
(96.0 %id)
EC559421 Prostate .a 819 to 918 100 to 1       100/100
(100 %)
0 diff
(100 %id)
BM970515 lung .a 826 to 1185 378 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 360/360
(100 %)
0 diff
(100 %id)
AA570219   .a 827 to 1190 9 to 372       364/374
(97 %)
4 diff
(99.0 %id)
AA573558   .a 827 to 1185 8 to 366       359/367
(97 %)
4 diff
(99.0 %id)
EC542630 Prostate .a 830 to 932 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
T62997 lung .a 832 to 1167 1 to 345       345/365
(94 %)
14 diff
(96.2 %id)
AA826173 germinal center B cell .a 833 to 1186 375 to 23   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 353/353
(100 %)
5 diff
(98.6 %id)
AA987195 carcinoid, lung .a 833 to 1312 480 to 3       478/480
(99 %)
0 diff
(100 %id)
DB566133 hypothalamus .a 843 to 1308 1 to 466     Submitted on the opposite strand 466/467
(99 %)
3 diff
(99.4 %id)
BF438531 brain, glioblastoma (pooled) .a 848 to 1186 340 to 1       340/340
(100 %)
11 diff
(96.8 %id)
DB556323 hypothalamus .a 855 to 1308 1 to 451     Submitted on the opposite strand 451/452
(99 %)
12 diff
(97.4 %id)
AA437128   .a 873 to 1185 314 to 3       312/314
(99 %)
0 diff
(100 %id)
AA912419 pooled .a 874 to 1185 316 to 4       313/316
(99 %)
0 diff
(100 %id)
AA889565   .a 876 to 1187 313 to 3       311/313
(99 %)
0 diff
(100 %id)
AA884570 pooled .a 876 to 1187 311 to 1       311/311
(100 %)
2 diff
(99.4 %id)
AI695582 colon .a 879 to 1190 313 to 2       312/422
(73 %)
0 diff
(100 %id)
DB561924 hypothalamus .a 881 to 1307 1 to 427     Submitted on the opposite strand 427/427
(100 %)
7 diff
(98.4 %id)
GD153108   .a 882 to 1144 1 to 266       266/304
(87 %)
13 diff
(95.8 %id)
FN166078 breast carcinoma .a 885 to 982 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
AA235019 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 890 to 1186 296 to 1       296/296
(100 %)
1 diff
(99.7 %id)
AI918748 pooled germ cell tumors .a 904 to 1187 285 to 2       284/285
(99 %)
0 diff
(100 %id)
AA837214 germinal center B cell .a 910 to 1186 310 to 35   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 276/276
(100 %)
1 diff
(99.7 %id)
W95158 heart .a 921 to 1186 272 to 1       272/310
(87 %)
7 diff
(97.8 %id)
BU627574 Bone, Enchondroma cell line .a 924 to 1186 281 to 19   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 263/264
(99 %)
0 diff
(100 %id)
AI420814 Prostate .a 936 to 1299 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AA740598 2 pooled tumors (clear cell type), Kidney .a 938 to 1190 253 to 2       252/253
(99 %)
0 diff
(100 %id)
AI351271 lung .a 957 to 1185 232 to 4       229/234
(97 %)
0 diff
(100 %id)
C00461   .a 1003 to 1188 1 to 186       186/186
(100 %)
0 diff
(100 %id)
AW299923 Kidney .a 1045 to 1309 265 to 1       265/265
(100 %)
2 diff
(99.3 %id)
BM798774 stomach .a 1067 to 1186 1 to 119   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 119/119
(100 %)
2 diff
(98.4 %id)
AI381769 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1069 to 1310 244 to 3       242/244
(99 %)
0 diff
(100 %id)
BM128841 Islets of Langerhans, Pancreas .a 1070 to 1188 119 to 1   fully sequenced,   119/119
(100 %)
1 diff
(99.2 %id)
AA234771 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1104 to 1185 83 to 3       81/83
(97 %)
0 diff
(100 %id)
CN273714 embryonic stem cells, DMSO-treated H9 cellline .a 1449 to 1677 1 to 229       229/229
(100 %)
0 diff
(100 %id)
R42597 whole brain .a 1480 to 1954 481 to 1   tiling clone,   481/484
(99 %)
14 diff
(97.2 %id)
CX873077 embryonic stem .a 1725 to 2500 1 to 775   tiling clone,   775/775
(100 %)
2 diff
(99.8 %id)
BM824208 Ascites, stomach .a 1970 to 2492 1 to 525       525/525
(100 %)
5 diff
(99.1 %id)
AI479402 anaplastic oligodendroglioma, brain .a 2021 to 2421 412 to 12   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 401/401
(100 %)
2 diff
(99.6 %id)
BE162077 head_neck .a 2130 to 2461 332 to 1     Submitted on the opposite strand 332/332
(100 %)
2 diff
(99.4 %id)
CB104715 stomach .a 2449 to 2905 1 to 464   tiling clone,   464/464
(100 %)
21 diff
(95.5 %id)
BG722003 testis .b 1 to 889 7 to 889 exact     889/893
(99 %)
23 diff
(97.5 %id)
BC012489 Kidney, hypernephroma .b 1 to 884 4 to 887 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 887/887
(100 %)
0 diff
(100 %id)
CD685440 normal nasopharynx .b 1 to 621 19 to 639 T178S     623/639
(97 %)
8 diff
(98.8 %id)
BG167543 hypernephroma, cell line, Kidney .b 1 to 493 3 to 515       512/992
(51 %)
34 diff
(96.6 %id)
BP872411 embryonal kidney .b 2 to 597 1 to 596       596/596
(100 %)
7 diff
(98.9 %id)
DB505617 hypothalamus .b 3 to 461 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BM740036 Ascites, stomach .b 6 to 565 1 to 560       560/560
(100 %)
4 diff
(99.3 %id)
R60617 whole brain .b 8 to 433 1 to 428     Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 428/513
(83 %)
6 diff
(98.9 %id)
AL693790   .b 9 to 566 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
BF573272 melanotic melanoma, high MDR, skin .b 9 to 754 1 to 745 T31P I32S C33A T34Q G35A ...     747/770
(97 %)
40 diff
(94.9 %id)
BF978621 melanotic melanoma, high MDR, skin .b 9 to 757 1 to 731 I84M A85H H86T I87L A89H ...     731/789
(92 %)
24 diff
(97.0 %id)
BQ717362 sympathetic trunk .b 9 to 495 1 to 489       489/1082
(45 %)
11 diff
(99.0 %id)
CB116289 Liver .b 9 to 194 1 to 186       186/186
(100 %)
2 diff
(99.0 %id)
BM755257 stomach .b 9 to 271 1 to 263       263/263
(100 %)
4 diff
(98.5 %id)
CD248821 embryonic stem cells, WA01, passage 38 .b 10 to 480 25 to 495   AAA   471/837
(56 %)
8 diff
(99.1 %id)
CB125366 Liver .b 10 to 297 1 to 289       289/300
(96 %)
19 diff
(93.7 %id)
BM751975 Ascites, stomach .b 10 to 357 1 to 349       349/349
(100 %)
1 diff
(99.8 %id)
BM754818 Ascites, stomach .b 10 to 483 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BM770070 Ascites, stomach .b 10 to 671 1 to 662 exact     662/662
(100 %)
0 diff
(100 %id)
BM770128 Ascites, stomach .b 10 to 472 1 to 463       463/463
(100 %)
0 diff
(100 %id)
BM770700 Ascites, stomach .b 10 to 465 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BM770730 Ascites, stomach .b 10 to 455 1 to 446       446/446
(100 %)
0 diff
(100 %id)
BM771278 Ascites, stomach .b 10 to 569 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BM771428 Ascites, stomach .b 10 to 682 1 to 673 exact     673/673
(100 %)
0 diff
(100 %id)
BM771455 Ascites, stomach .b 10 to 674 1 to 665 exact     665/665
(100 %)
0 diff
(100 %id)
BM771945 Ascites, stomach .b 10 to 730 1 to 721 exact     721/721
(100 %)
0 diff
(100 %id)
BM742160 stomach .b 10 to 642 1 to 633 exact     633/633
(100 %)
0 diff
(100 %id)
BM783441 stomach .b 10 to 621 1 to 612 exact     612/612
(100 %)
0 diff
(100 %id)
AW248400 lung, small cell carcinoma .b 11 to 473 10 to 472       463/472
(98 %)
6 diff
(98.8 %id)
BM754817 Ascites, stomach .b 11 to 548 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BM751974 Ascites, stomach .b 13 to 524 1 to 506       506/506
(100 %)
19 diff
(96.3 %id)
TI_1948145519   .b 19 to 493 130 to 605       476/1451
(32 %)
13 diff
(99.2 %id)
CV023986 mixed .b 20 to 600 1 to 581       581/646
(89 %)
1 diff
(99.9 %id)
BE780849 eye, retinoblastoma .b 20 to 752 1 to 726 G184X R186A R188G K189R A190S ...     726/731
(99 %)
16 diff
(97.9 %id)
BM740227 Ascites, stomach .b 20 to 473 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
BI116264 lung, small cell carcinoma .b 21 to 884 1 to 863       863/898
(96 %)
20 diff
(97.8 %id)
BP429714   .b 21 to 387 1 to 367       367/367
(100 %)
3 diff
(99.2 %id)
BM789003 Ascites, stomach .b 23 to 520 1 to 499       499/499
(100 %)
7 diff
(98.6 %id)
BI047532 stomach .b 25 to 259 275 to 41       235/275
(85 %)
0 diff
(100 %id)
AA471252   .b 26 to 374 1 to 347       347/347
(100 %)
3 diff
(99.2 %id)
BG912093 anaplastic oligodendroglioma with 1p/19qloss, brain .b 26 to 683 1 to 655       655/655
(100 %)
5 diff
(99.3 %id)
AV706213 adrenal gland .b 31 to 659 1 to 629       629/629
(100 %)
13 diff
(98.0 %id)
BG115047 duodenal adenocarcinoma, cell line, small intestine .b 31 to 831 1 to 793       793/944
(84 %)
18 diff
(98.1 %id)
BQ670842 epidermoid carcinoma, cell line, salivary gland .b 31 to 878 13 to 869       857/967
(88 %)
23 diff
(97.7 %id)
BG470056 adenocarcinoma cell line, colon .b 32 to 823 1 to 794       794/794
(100 %)
3 diff
(99.7 %id)
AA157921 Pancreas .b 33 to 427 1 to 396       396/428
(92 %)
6 diff
(98.6 %id)
AW404111 lymph .b 33 to 321 1 to 292       289/292
(98 %)
7 diff
(97.7 %id)
BG027461 Bone, osteosarcoma, cell line .b 33 to 816 1 to 765       765/888
(86 %)
28 diff
(96.9 %id)
BQ069101 brain, neuroblastoma, cell line .b 34 to 887 1 to 854   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 854/854
(100 %)
5 diff
(99.5 %id)
BM480183 duodenal adenocarcinoma, cell line, small intestine .b 35 to 709 1 to 681       681/1096
(62 %)
20 diff
(98.2 %id)
BQ674763 epidermoid carcinoma, cell line, salivary gland .b 35 to 746 23 to 738       716/951
(75 %)
28 diff
(97.1 %id)
BM008909 adenocarcinoma, Pancreas .b 48 to 765 1 to 720       720/720
(100 %)
4 diff
(99.5 %id)
TI_59386628   .b 48 to 765 104 to 823       720/720
(100 %)
4 diff
(99.5 %id)
BE883171 leiomyosarcoma, uterus .b 51 to 815 1 to 758       758/871
(87 %)
21 diff
(97.6 %id)
AA157856 Pancreas .b 493 to 872 380 to 1       380/392
(96 %)
7 diff
(98.3 %id)
R60561 whole brain .b 818 to 1008 204 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 190/190
(100 %)
1 diff
(99.5 %id)
BF968789 adrenal cortex carcinoma, cell line, adrenal gland .c 1 to 753 1 to 752 R126P V127S V128C V129G K130E ... tiling clone,   752/752
(100 %)
6 diff
(99.3 %id)
BQ222332 epithelioid carcinoma, Pancreas .c 54 to 918 1 to 872 exact tiling clone,   872/874
(99 %)
25 diff
(97.2 %id)
DB264636 uterus .d 1 to 592 2 to 593 exact tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
CU445884 epidermis .d 455 to 665 214 to 3   tiling clone, Submitted on the opposite strand 212/227
(93 %)
0 diff
(100 %id)
NM_176805.1   .e 1 to 1031 1 to 1031 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 1031/1031
(100 %)
0 diff
(100 %id)
BF984358 duodenal adenocarcinoma, cell line, small intestine .e 244 to 933 1 to 691 exact tiling clone,   691/901
(76 %)
9 diff
(99.1 %id)
CD176129 embryonic stem cells, WA01, passage 38 .e 256 to 1039 17 to 800 exact tiling clone,   784/815
(96 %)
10 diff
(98.8 %id)
BC009451 Muscle, rhabdomyosarcoma .e 269 to 1031 1 to 763   available from MGC, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 763/763
(100 %)
0 diff
(100 %id)
BQ059220 lymph, lymphoma, cell line .e 275 to 1037 1 to 761   tiling clone,   761/771
(98 %)
2 diff
(99.8 %id)
BF315280 brain, neuroblastoma .e 276 to 1000 1 to 726       726/874
(83 %)
9 diff
(99.0 %id)
BE313134 brain, neuroblastoma .e 296 to 1000 1 to 700       700/713
(98 %)
22 diff
(97.0 %id)
AK027059   .f 1 to 2002 1 to 2000 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 2000/2000
(100 %)
3 diff
(99.9 %id)
DA533301 brain .f 3 to 564 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DA009182 adrenal gland .f 4 to 561 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
EL951370 eyeball .f 1220 to 1685 13 to 478       466/478
(97 %)
6 diff
(98.8 %id)
TI_57186095   .g 1 to 623 112 to 736 S5K R6Q L8V N9E R10Q ... tiling clone,   633/687
(92 %)
9 diff
(98.7 %id)
AA215875   .g 2 to 236 1 to 231       231/232
(99 %)
14 diff
(94.0 %id)
BU175439 large cell carcinoma, lung .g 2 to 843 1 to 852 exact tiling clone,   852/873
(97 %)
18 diff
(98.0 %id)
BM966864 Islets of Langerhans, Pancreas .h 1 to 553 14 to 566 exact tiling clone, fully sequenced,   558/566
(98 %)
6 diff
(99.0 %id)
BM893627 Islets of Langerhans, Pancreas .h 139 to 554 421 to 6   fully sequenced,   416/421
(98 %)
0 diff
(100 %id)
AI915613 pooled .h 286 to 552 282 to 16   AAA   267/270
(98 %)
0 diff
(100 %id)
BU535933 mixed (pool of 40 RNAs) .h 438 to 558 7 to 127   AAA   121/127
(95 %)
6 diff
(95.3 %id)
CA425984 Bone, Subchondral Bone .h 441 to 1180 757 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 739/739
(100 %)
1 diff
(99.9 %id)
AA031607 uterus .i 1 to 200 8 to 208   tiling clone,   208/208
(100 %)
4 diff
(98.1 %id)
BE621219 epithelioid carcinoma, Pancreas .i 13 to 726 1 to 705 I63M A64H H65T I66L A68H ... tiling clone,   705/705
(100 %)
13 diff
(98.2 %id)
BE621879 epithelioid carcinoma, Pancreas .i 14 to 784 775 to 3 N30D tiling clone,   773/775
(99 %)
1 diff
(99.9 %id)
BM825096 Ascites, stomach .i 261 to 796 27 to 562   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 536/562
(95 %)
6 diff
(99.0 %id)
AA031363 uterus .i 641 to 797 156 to 1   tiling clone,   156/156
(100 %)
1 diff
(99.4 %id)
CD172722 embryonic stem cells, WA01, passage 38 .j 1 to 456 23 to 477   tiling clone, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 455/477
(95 %)
6 diff
(98.8 %id)
BG398402 B-cells, primary B-cells from tonsils (cell line) .j 21 to 456 1 to 436   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 436/436
(100 %)
1 diff
(99.8 %id)
AW139861   .j 52 to 462 428 to 18   AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 411/411
(100 %)
1 diff
(99.8 %id)
BF434829 Kidney .j 53 to 463 413 to 2       412/413
(99 %)
0 diff
(100 %id)
CD050977 embryonic trophoblasts, made from WA01 stemcells .k 1 to 457 25 to 481 exact AAA   457/496
(92 %)
6 diff
(98.8 %id)
CD051024 embryonic trophoblasts, made from WA01 stemcells .k 1 to 450 25 to 474 exact tiling clone, AAA   450/474
(94 %)
6 diff
(98.8 %id)
DA239015 brain .k 32 to 614 2 to 584 exact capped   583/583
(100 %)
0 diff
(100 %id)
BF685657 leiomyosarcoma cell line, uterus .k 51 to 854 1 to 801   tiling clone,   801/1128
(71 %)
29 diff
(97.5 %id)
BF684686 leiomyosarcoma cell line, uterus .k 51 to 810 1 to 752   tiling clone,   752/957
(78 %)
31 diff
(96.8 %id)
DA346747 substantia nigra .l-u 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA794699 brain .l-u 11 to 576 2 to 567 exact capped   566/566
(100 %)
0 diff
(100 %id)
BG394270 eye, retinoblastoma .l-u 12 to 740 1 to 726 exact     726/954
(76 %)
11 diff
(98.9 %id)
BC000200 Eye, retinoblastoma .l-u 13 to 1311 1 to 1299 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 1299/1299
(100 %)
0 diff
(100 %id)
DA062987 cerebellum .l-u 16 to 570 2 to 556 exact capped   555/555
(100 %)
0 diff
(100 %id)
DA617288   .l-u 30 to 606 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BE254918 eye, retinoblastoma .l-u 33 to 688 1 to 679   available from MGC,   679/699
(97 %)
35 diff
(95.0 %id)
AW858942 colon .l-u 751 to 1210 458 to 1       458/462
(99 %)
12 diff
(97.5 %id)
BQ317563 colon .l-u 758 to 1210 452 to 1       452/455
(99 %)
5 diff
(99.0 %id)
CN348795 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l-u 1181 to 1446 1 to 266   tiling clone,   266/266
(100 %)
4 diff
(98.5 %id)
BQ364025 stomach .l-u 1245 to 1491 275 to 27   tiling clone,   249/304
(81 %)
0 diff
(100 %id)
CA314427 Human Lung Epithelial cells, lung .m 1 to 722 740 to 19 G20V tiling clone, AAA Possibly primed on the genome, locally A rich (20/21 A in genome downstream of last aligned base) 722/722
(100 %)
2 diff
(99.8 %id)
AW263997 brain, three pooled meningiomas .m 253 to 722 470 to 1 exact tiling clone,   470/470
(100 %)
2 diff
(99.6 %id)
AW264035 brain, three pooled meningiomas .m 253 to 722 470 to 1 exact tiling clone,   470/470
(100 %)
2 diff
(99.6 %id)
DA803430 brain .n 1 to 503 2 to 504 exact tiling clone, capped   503/503
(100 %)
0 diff
(100 %id)
BG960270 colon Gene MRPS11, variant not shown              
DA057197 cerebellum Gene MRPS11, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA125039 cerebellum Gene MRPS11, variant not shown       capped      
DB302865.
matches multiple genes
amygdala Gene kyswy, variant not shown         This clone was ignored, also hits gene kyswy    
DB302865.
matches multiple genes
amygdala Gene MRPS11, variant not shown         This clone was ignored, also hits gene kyswy    
DA179151.
matches multiple genes
amygdala Gene kyswy, variant not shown       capped This clone was ignored, also hits gene kyswy    
DA179151.
matches multiple genes
amygdala Gene MRPS11, variant not shown       capped This clone was ignored, also hits gene kyswy    
AL599270   Gene MRPS11, variant not shown              
AV688389 hepatocellular carcinoma Gene MRPS11, variant not shown         Suspected internal deletion, this clone was ignored    
AV689546 hepatocellular carcinoma Gene MRPS11, variant not shown         Suspected internal deletion, this clone was ignored    
AV728366 hypothalamus Gene MRPS11, variant not shown         Suspected internal deletion, this clone was ignored    
AI817324 normal prostate, Prostate Gene MRPS11, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DB151157 thymus Gene MRPS11, variant not shown       capped      
DB346141 thymus Gene MRPS11, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C